Skip to main content

Table 2 Mutations *1 related to resistance against baloxavir marboxil among type A influenza isolates from patients with influenza in Kawasaki Medical School Hospital during the 2023–2024 flu season

From: Efficacy of baloxavir marboxil as a prophylactic against influenza among in-patients and analysis of influenza virus mutations in their isolates at a Japanese hospital during the 2023–2024 flu season

  1. NS Not Significant
  2. *1The isoleucine-38 (I38) T variant of the cap-dependent endonuclease-baloxavir marboxil complex structure was detected  
  3. *2The two cases with the I38T variant were a 28-year-old woman and a 57-year-old man. Both were infected by their children
Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us